Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Non-Current Assets: 2014-2024

Historic Other Non-Current Assets for KalVista Pharmaceuticals (KALV) over the last 7 years, with Apr 2024 value amounting to $567,000.

  • KalVista Pharmaceuticals' Other Non-Current Assets was N/A to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $567,000 for FY2024, which is N/A change from last year.
  • As of FY2024, KalVista Pharmaceuticals' Other Non-Current Assets stood at $567,000, which was up 218.54% from $178,000 recorded in FY2020.
  • Over the past 5 years, KalVista Pharmaceuticals' Other Non-Current Assets peaked at $567,000 during FY2024, and registered a low of $178,000 during FY2020.
  • Over the past 1 years, KalVista Pharmaceuticals' median Other Non-Current Assets value was $567,000 (recorded in 2024), while the average stood at $567,000.
  • Data for KalVista Pharmaceuticals' Other Non-Current Assets shows a peak YoY rose of 2.89% (in 2020) over the last 5 years.
  • KalVista Pharmaceuticals' Other Non-Current Assets (Yearly) stood at $178,000 in 2020, then followed by $567,000 in 2024.